Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Protoacoustic Imaging For 3D Mapping

NCT: NCT07832617 · RECRUITING

NCT IDNCT07832617
StatusRECRUITING
Start Date2026-06-10
Completion2030-06
SponsorUniversity of Oklahoma (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to test a new imaging technology called radioacoustic imaging (RAI) that may help doctors see where radiation is being delivered during proton therapy. During proton therapy, the radiation treatment produces very small sound signals inside the body. This study will use special ultrasound sensors placed on the outside of the body to detect these signals. The information collected may allow researchers to create a picture showing where the radiation dose is being delivered in the body and how much radiation is reaching the treatment area. The goal is to determine whether this technology can safely and accurately measure radiation during proton therapy without requiring any additional procedures or radiation exposure.

Frequently Asked Questions

What is Protoacoustic Imaging For 3D Mapping?

Protoacoustic Imaging For 3D Mapping is a clinical trial registered under NCT07832617. Current status: RECRUITING.

What is the status of NCT07832617?

The current status of NCT07832617 (Protoacoustic Imaging For 3D Mapping) is: RECRUITING.

When did Protoacoustic Imaging For 3D Mapping start?

Protoacoustic Imaging For 3D Mapping started on 2026-06-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.